trending Market Intelligence /marketintelligence/en/news-insights/trending/lfwvx4vkeo6te7tkpnizqw2 content esgSubNav
In This List

Unum Therapeutics prices IPO

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


Unum Therapeutics prices IPO

Cambridge, Mass.-based Unum Therapeutics Inc. priced its IPO of 5,770,000 shares at $12 apiece.

The IPO is expected to close by April 3 with Morgan Stanley and Cowen acting as joint book-running managers and SunTrust Robinson Humphrey and Wedbush PacGrow acting as lead managers.

The biotechnology company granted underwriters an option to purchase up to an additional 865,500 shares.

The company's stock will start trading on the Nasdaq Global Select Market under the ticker symbol UMRX on March 29.